Skip to main content

ED Utilization by Psoriatic and Spondyloarthritis Patients A cohort analysis of ambulatory ED utilization by patients w

Social Author Name
Dr. John Cush
Tweet Content
ED Utilization by Psoriatic and Spondyloarthritis Patients A cohort analysis of ambulatory ED utilization by patients with PsA and r-axSpA demonstrated significant use for less urgent and nonurgent health issues, particularly in rural settings. https://t.co/Pl9k3GN0mp https://t.co/kI1rOue9ws

Intraarticular Steroids in OA Lowers Need for Pain Meds Is it possible that intra-articular corticosteroid injections

Social Author Name
Dr. John Cush
Tweet Content
Intraarticular Steroids in OA Lowers Need for Pain Meds Is it possible that intra-articular corticosteroid injections for osteoarthritis might affect the use of opioids? https://t.co/qkTN7CpuMZ https://t.co/npuT88Sj2m

Hydroxychloroquine and Sjögren's - despite widespread use, there is not good data showing HCQ efficacy in Sjogrens. Alt

Social Author Name
Dr. John Cush
Tweet Content
Hydroxychloroquine and Sjögren's - despite widespread use, there is not good data showing HCQ efficacy in Sjogrens. Although safe and may lower Ig levels - 3 RCTs found no clinical benefit, but retrospective & open-label studies did https://t.co/8l1gZoKqFA https://t.co/JNGmpnNMHx
Long-Term Use of NSAIDs Linked to Lower Dementia Risk
Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs) was tied to a decreased risk of dementia, data from the prospective Rotterdam Study showed.

Early Hydroxychloroquine Slows Cutaneous Lupus Progression A prospective study of patients with limited cutaneous lupu

Social Author Name
Dr. John Cush
Tweet Content
Early Hydroxychloroquine Slows Cutaneous Lupus Progression A prospective study of patients with limited cutaneous lupus erythematosus (CLE) shows that early introduction of hydroxychloroquine (HCQ) may prevent progression to systemic lupus erythematosus (SLE).… https://t.co/evsvf2GQiL https://t.co/J0Zl35FEHz

Bimekizumab efficacy and safety in patients with psoriatic arthritis who had skin and nail psoriasis at baseline: Up to

Social Author Name
Dr. John Cush
Tweet Content
Bimekizumab efficacy and safety in patients with psoriatic arthritis who had skin and nail psoriasis at baseline: Up to 2-year results from two phase 3 studies https://t.co/QGdQtp3Mbe

"Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it's the only thing that

Social Author Name
Dr. John Cush
Tweet Content
"Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it's the only thing that ever has." - Margaret Mead

Full read review of Hydryoxychloroquine -its pharmacology, MOA (eg, blocking TLR 7 & 9), Dz specific efficacy and ad

Social Author Name
Dr. John Cush
Tweet Content
Full read review of Hydryoxychloroquine -its pharmacology, MOA (eg, blocking TLR 7 & 9), Dz specific efficacy and adverse effects https://t.co/N7XVbfnsfi https://t.co/yjKwcfugOJ

Bubble Trouble - When Bullous Lupus Bursts onto the SLE Scene Presentation by Dr. Alana Haussmann at the Rheumatology

Social Author Name
Dr. John Cush
Tweet Content
Bubble Trouble - When Bullous Lupus Bursts onto the SLE Scene Presentation by Dr. Alana Haussmann at the Rheumatology Winter Clinical Symposia - Feb 2025 https://t.co/N4u4AUbdqH https://t.co/PotKfpOkH7

Available the first time: https://t.co/4UQlqwujiR 2025 On Demand! On Demand gives you access to all lectures, Q & A

Social Author Name
Dr. John Cush
Tweet Content
Available the first time: https://t.co/4UQlqwujiR 2025 On Demand! On Demand gives you access to all lectures, Q & A panels, and STEP talks, and all speaker slides and handouts — all packed with insights you won’t find anywhere else. Non-CME, practical, and finally here.… https://t.co/MHFUWb3az1 https://t.co/cqzZG40Xp5
Subscribe to
×